Please Wait.....
Report
Hospital Emergency Department Market By Insurance Type (Medicare and Medicaid, Private and Others) , By Condition (Traumatic, Infectious, Gastrointestinal, Psychiatric, Cardiac, Neurologic, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 222 Pages I Allied Market Research
The global hospital emergency department market was valued at $135.0 billion in 2023, and is projected to reach $202.2 billion by 2033, growing at a CAGR of 4.1% from 2024 to 2033.
The hospital emergency department (ED), often referred to as the emergency room (ER) or casualty department (in some regions), is a specialized medical facility within a hospital that provides immediate care to patients with acute medical conditions or injuries. These conditions typically require urgent attention but may not be severe or life-threatening enough to necessitate admission to the hospital. The primary function of the emergency department is to assess, stabilize, and initiate treatment for patients who arrive without prior appointments, 24 hours a day, 7 days a week.
The growth of the hospital emergency department market is driven by increase in incidence of chronic diseases and rise in the prevalence of injuries and accidents which necessitate urgent medical care, thereby boosting demand for emergency department services. Moreover, initiatives by major players toward several facilities drive the growth of the market. For instance, Sanjay Gandhi Memorial Hospital (SGMH) introduced several new initiatives during the financial year 2022-23 to enhance services, including mandatory Thalassemia screening for pregnant women, daily OPDs in all departments, strengthening of ICU services, and adjustments in OPD and doctor timings to improve patient care and reduce incidents of violence among doctors and the public.
However, high operational costs associated with maintaining and staffing emergency departments strain hospital budgets and resources. On the other hand, rise in demand for emergency medical care and surge in value-based care and population health management within the healthcare industry present significant opportunity for the key players in the hospital emergency department market to expand their services. For instance, in July 2022, Lakeland Regional Health expanded to meet the needs of the community. The health system has started planning for an additional location in south Lakeland on a 5.6-acre property Florida Avenue.
Segmentation Overview
The hospital emergency department market is segmented into insurance type, condition, and region. Depending on insurance type, the market is categorized into Medicare & Medicaid and private & others. As per condition, it is divided into traumatic, infectious, gastrointestinal, psychiatric, cardiac, neurologic, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By insurance type, the private and others segment held the highest market share in 2023.
Depending on condition, the infectious segment accounted for the largest share in the market in 2023.
Region wise, North America dominated the hospital emergency department market in 2023.
Competitive Analysis
The major players operating in the hospital emergency department market include Parkland Health, Hartford Hospital, Lakeland Regional Health, St. Joseph's Health, HCA, Inc., Siemens, The General Hospital Corporation, Mayo Clinic Hospital, Brigham and Women's Hospital, and Barnes-Jewish Hospital. These players have been involved in different tactics such as mergers & acquisitions, partnerships, collaborations, product diversification, and marketing & advertising to sustain their position in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Insurance Type
- Medicare and Medicaid
- Private and Others
By Condition
- Traumatic
- Infectious
- Gastrointestinal
- Psychiatric
- Cardiac
- Neurologic
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Parkland Health
- Koninklijke Philips N.V.
- Lakeland Regional Health
- St. Joseph's Health
- HCA, Inc.
- Siemens
- The General Hospital Corporation
- Mayo Clinic Hospital
- Brigham and Women's Hospital
- Barnes-Jewish Hospital
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY SERVICE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Service
4.2. Immune Boosters
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Energy Boosters
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Skin Care
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Migraine
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Others
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
CHAPTER 5: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY COMPONENT
5.1. Market Overview
5.1.1 Market Size and Forecast, By Component
5.2. Medicated
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Non-medicated
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospital Clinics
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Wellness Centers Spas
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Home Healthcare
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Others
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Service
7.2.3. Market Size and Forecast, By Component
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Intravenous (IV) Hydration Therapy Market
7.2.6.1. Market Size and Forecast, By Service
7.2.6.2. Market Size and Forecast, By Component
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Intravenous (IV) Hydration Therapy Market
7.2.7.1. Market Size and Forecast, By Service
7.2.7.2. Market Size and Forecast, By Component
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Intravenous (IV) Hydration Therapy Market
7.2.8.1. Market Size and Forecast, By Service
7.2.8.2. Market Size and Forecast, By Component
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Service
7.3.3. Market Size and Forecast, By Component
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Intravenous (IV) Hydration Therapy Market
7.3.6.1. Market Size and Forecast, By Service
7.3.6.2. Market Size and Forecast, By Component
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Intravenous (IV) Hydration Therapy Market
7.3.7.1. Market Size and Forecast, By Service
7.3.7.2. Market Size and Forecast, By Component
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Intravenous (IV) Hydration Therapy Market
7.3.8.1. Market Size and Forecast, By Service
7.3.8.2. Market Size and Forecast, By Component
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Intravenous (IV) Hydration Therapy Market
7.3.9.1. Market Size and Forecast, By Service
7.3.9.2. Market Size and Forecast, By Component
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Intravenous (IV) Hydration Therapy Market
7.3.10.1. Market Size and Forecast, By Service
7.3.10.2. Market Size and Forecast, By Component
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Intravenous (IV) Hydration Therapy Market
7.3.11.1. Market Size and Forecast, By Service
7.3.11.2. Market Size and Forecast, By Component
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Service
7.4.3. Market Size and Forecast, By Component
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Intravenous (IV) Hydration Therapy Market
7.4.6.1. Market Size and Forecast, By Service
7.4.6.2. Market Size and Forecast, By Component
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Intravenous (IV) Hydration Therapy Market
7.4.7.1. Market Size and Forecast, By Service
7.4.7.2. Market Size and Forecast, By Component
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Intravenous (IV) Hydration Therapy Market
7.4.8.1. Market Size and Forecast, By Service
7.4.8.2. Market Size and Forecast, By Component
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Intravenous (IV) Hydration Therapy Market
7.4.9.1. Market Size and Forecast, By Service
7.4.9.2. Market Size and Forecast, By Component
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Intravenous (IV) Hydration Therapy Market
7.4.10.1. Market Size and Forecast, By Service
7.4.10.2. Market Size and Forecast, By Component
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Intravenous (IV) Hydration Therapy Market
7.4.11.1. Market Size and Forecast, By Service
7.4.11.2. Market Size and Forecast, By Component
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Service
7.5.3. Market Size and Forecast, By Component
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Intravenous (IV) Hydration Therapy Market
7.5.6.1. Market Size and Forecast, By Service
7.5.6.2. Market Size and Forecast, By Component
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Intravenous (IV) Hydration Therapy Market
7.5.7.1. Market Size and Forecast, By Service
7.5.7.2. Market Size and Forecast, By Component
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Intravenous (IV) Hydration Therapy Market
7.5.8.1. Market Size and Forecast, By Service
7.5.8.2. Market Size and Forecast, By Component
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Intravenous (IV) Hydration Therapy Market
7.5.9.1. Market Size and Forecast, By Service
7.5.9.2. Market Size and Forecast, By Component
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Davita
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Nikkiso Co. Ltd.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Core IV Therapy, LLC
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Cryojuvenate UK Ltd.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. B. Braun Medical Inc.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Otsuka Pharmaceutical Co., Ltd.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. NexGen Health
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. JW Life Science Corporation
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Amanta Healthcare Limited.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Baxter International Inc.?
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 2. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR MEDICARE AND MEDICAID, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR PRIVATE AND OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 5. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR TRAUMATIC, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR INFECTIOUS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR GASTROINTESTINAL, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR PSYCHIATRIC, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR CARDIAC, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR NEUROLOGIC, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. HOSPITAL EMERGENCY DEPARTMENT MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. NORTH AMERICA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 16. U.S. HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 17. U.S. HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 18. CANADA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 19. CANADA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 20. MEXICO HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 21. MEXICO HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 22. EUROPE HOSPITAL EMERGENCY DEPARTMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 23. EUROPE HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 24. EUROPE HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 25. GERMANY HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 26. GERMANY HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 27. FRANCE HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 28. FRANCE HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 29. UK HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 30. UK HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 31. ITALY HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 32. ITALY HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 33. SPAIN HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 34. SPAIN HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 35. REST OF EUROPE HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 36. REST OF EUROPE HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 37. ASIA-PACIFIC HOSPITAL EMERGENCY DEPARTMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 38. ASIA-PACIFIC HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 39. ASIA-PACIFIC HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 40. JAPAN HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 41. JAPAN HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 42. CHINA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 43. CHINA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 44. INDIA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 45. INDIA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 46. AUSTRALIA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 47. AUSTRALIA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 48. SOUTH KOREA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 49. SOUTH KOREA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 50. REST OF ASIA-PACIFIC HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 51. REST OF ASIA-PACIFIC HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 52. LAMEA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 53. LAMEA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 54. LAMEA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 55. BRAZIL HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 56. BRAZIL HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 57. SAUDI ARABIA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 58. SAUDI ARABIA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 59. SOUTH AFRICA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 60. SOUTH AFRICA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 61. REST OF LAMEA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY INSURANCE TYPE, 2024 - 2033 ($BILLION)
TABLE 62. REST OF LAMEA HOSPITAL EMERGENCY DEPARTMENT MARKET, BY CONDITION, 2024 - 2033 ($BILLION)
TABLE 63. PARKLAND HEALTH: KEY EXECUTIVES
TABLE 64. PARKLAND HEALTH: COMPANY SNAPSHOT
TABLE 65. PARKLAND HEALTH: OPERATING SEGMENTS
TABLE 66. PARKLAND HEALTH: PRODUCT PORTFOLIO
TABLE 67. PARKLAND HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 68. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 69. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 70. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 71. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 72. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 73. LAKELAND REGIONAL HEALTH: KEY EXECUTIVES
TABLE 74. LAKELAND REGIONAL HEALTH: COMPANY SNAPSHOT
TABLE 75. LAKELAND REGIONAL HEALTH: OPERATING SEGMENTS
TABLE 76. LAKELAND REGIONAL HEALTH: PRODUCT PORTFOLIO
TABLE 77. LAKELAND REGIONAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 78. ST. JOSEPH'S HEALTH: KEY EXECUTIVES
TABLE 79. ST. JOSEPH'S HEALTH: COMPANY SNAPSHOT
TABLE 80. ST. JOSEPH'S HEALTH: OPERATING SEGMENTS
TABLE 81. ST. JOSEPH'S HEALTH: PRODUCT PORTFOLIO
TABLE 82. ST. JOSEPH'S HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 83. HCA, INC.: KEY EXECUTIVES
TABLE 84. HCA, INC.: COMPANY SNAPSHOT
TABLE 85. HCA, INC.: OPERATING SEGMENTS
TABLE 86. HCA, INC.: PRODUCT PORTFOLIO
TABLE 87. HCA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 88. SIEMENS: KEY EXECUTIVES
TABLE 89. SIEMENS: COMPANY SNAPSHOT
TABLE 90. SIEMENS: OPERATING SEGMENTS
TABLE 91. SIEMENS: PRODUCT PORTFOLIO
TABLE 92. SIEMENS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 93. THE GENERAL HOSPITAL CORPORATION: KEY EXECUTIVES
TABLE 94. THE GENERAL HOSPITAL CORPORATION: COMPANY SNAPSHOT
TABLE 95. THE GENERAL HOSPITAL CORPORATION: OPERATING SEGMENTS
TABLE 96. THE GENERAL HOSPITAL CORPORATION: PRODUCT PORTFOLIO
TABLE 97. THE GENERAL HOSPITAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 98. MAYO CLINIC HOSPITAL: KEY EXECUTIVES
TABLE 99. MAYO CLINIC HOSPITAL: COMPANY SNAPSHOT
TABLE 100. MAYO CLINIC HOSPITAL: OPERATING SEGMENTS
TABLE 101. MAYO CLINIC HOSPITAL: PRODUCT PORTFOLIO
TABLE 102. MAYO CLINIC HOSPITAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103. BRIGHAM AND WOMEN'S HOSPITAL: KEY EXECUTIVES
TABLE 104. BRIGHAM AND WOMEN'S HOSPITAL: COMPANY SNAPSHOT
TABLE 105. BRIGHAM AND WOMEN'S HOSPITAL: OPERATING SEGMENTS
TABLE 106. BRIGHAM AND WOMEN'S HOSPITAL: PRODUCT PORTFOLIO
TABLE 107. BRIGHAM AND WOMEN'S HOSPITAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108. BARNES-JEWISH HOSPITAL: KEY EXECUTIVES
TABLE 109. BARNES-JEWISH HOSPITAL: COMPANY SNAPSHOT
TABLE 110. BARNES-JEWISH HOSPITAL: OPERATING SEGMENTS
TABLE 111. BARNES-JEWISH HOSPITAL: PRODUCT PORTFOLIO
TABLE 112. BARNES-JEWISH HOSPITAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL HOSPITAL EMERGENCY DEPARTMENT MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF HOSPITAL EMERGENCY DEPARTMENT MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN HOSPITAL EMERGENCY DEPARTMENT MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHOSPITAL EMERGENCY DEPARTMENT MARKET
FIGURE 10. GLOBAL HOSPITAL EMERGENCY DEPARTMENT MARKET SEGMENTATION, BY INSURANCE TYPE
FIGURE 11. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR MEDICARE AND MEDICAID, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR PRIVATE AND OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL HOSPITAL EMERGENCY DEPARTMENT MARKET SEGMENTATION, BY CONDITION
FIGURE 14. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR TRAUMATIC, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR INFECTIOUS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR GASTROINTESTINAL, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR PSYCHIATRIC, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR CARDIAC, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR NEUROLOGIC, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. HOSPITAL EMERGENCY DEPARTMENT MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 25. COMPETITIVE DASHBOARD
FIGURE 26. COMPETITIVE HEATMAP: HOSPITAL EMERGENCY DEPARTMENT MARKET
FIGURE 27. TOP PLAYER POSITIONING, 2023
FIGURE 28. PARKLAND HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 29. PARKLAND HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 30. PARKLAND HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 31. KONINKLIJKE PHILIPS N.V.: NET SALES, 2021-2023 ($BILLION)
FIGURE 32. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. LAKELAND REGIONAL HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. LAKELAND REGIONAL HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. LAKELAND REGIONAL HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. ST. JOSEPH'S HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. ST. JOSEPH'S HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. ST. JOSEPH'S HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. HCA, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. HCA, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. HCA, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. SIEMENS: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. SIEMENS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. SIEMENS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. THE GENERAL HOSPITAL CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. THE GENERAL HOSPITAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. THE GENERAL HOSPITAL CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. MAYO CLINIC HOSPITAL: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. MAYO CLINIC HOSPITAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. MAYO CLINIC HOSPITAL: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. BRIGHAM AND WOMEN'S HOSPITAL: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. BRIGHAM AND WOMEN'S HOSPITAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. BRIGHAM AND WOMEN'S HOSPITAL: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 55. BARNES-JEWISH HOSPITAL: NET SALES, 2021-2023 ($BILLION)
FIGURE 56. BARNES-JEWISH HOSPITAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 57. BARNES-JEWISH HOSPITAL: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security